Medication info
Pimamon Tablet 30 mg (Pimasartan Potassium Trihydrate)

Pimamon Tablet 30 mg (Pimasartan Potassium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tablet
Manufacturer / importer
Dongkuk Pharm Co., Ltd.
Appearance
Light green, oval-shaped film-coated tablet with rounded edges
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202402924 · Approved 2024.12.11 · Insurance code 653405850

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take this medicine at the same time every day (e.g., in the morning). The blood pressure-lowering effect occurs within 2 weeks of starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. No initial dose adjustment is required in elderly patients aged 70 years or younger. For patients over 70 years of age, the recommended initial dose is 30 mg of this medicine once daily. (See section 9. Administration to elderly patients under Precautions for Use.) No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. No dose adjustment is required in patients with mild hepatic impairment; however, do not administer this medicine to patients with moderate to severe hepatic impairment (see sections 2. Patients who must not receive this medicine and 10. Administration to patients with hepatic impairment under Precautions for Use). For patients at high risk of hypotension, such as those with reduced effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients who require careful administration under Precautions for Use.)
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Dongkuk Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat hypertension, particularly essential hypertension.

How to take

Adult dose

Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take this medicine at the same time every day (e.g., in the morning). The blood pressure-lowering effect occurs within 2 weeks of starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. No initial dose adjustment is required in elderly patients aged 70 years or younger. For patients over 70 years of age, the recommended initial dose is 30 mg of this medicine once daily. (See section 9. Administration to elderly patients under Precautions for Use.) No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. No dose adjustment is required in patients with mild hepatic impairment; however, do not administer this medicine to patients with moderate to severe hepatic impairment (see sections 2. Patients who must not receive this medicine and 10. Administration to patients with hepatic impairment under Precautions for Use). For patients at high risk of hypotension, such as those with reduced effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients who require careful administration under Precautions for Use.)

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious damage or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Individuals allergic to any component of this medication, pregnant or nursing women, patients on kidney dialysis, patients with moderate to severe liver dysfunction, patients with biliary obstruction, and those with specific kidney diseases or diabetic nephropathy should not take this medication. Patients with low blood volume or salt content, impaired kidney function, renovascular hypertension, aortic or mitral stenosis, and primary aldosteronism should use this medication cautiously and be closely monitored. Mild side effects such as headache or dizziness may occur frequently with this medication, and rarely, symptoms such as indigestion, vomiting, elevated liver enzyme levels, cough, muscle pain, skin rash, and low blood pressure may manifest. Symptoms of low blood pressure may occur at the beginning of treatment or when increasing the dose, so blood pressure and electrolyte status should be checked regularly, and appropriate action should be taken if symptoms are severe. This medication can increase serum potassium levels, so patients with heart failure or kidney disease should have their potassium levels regularly checked. When taken with other antihypertensives, potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs, the interaction may increase the risk of side effects, thus consultation with a doctor or pharmacist is required. Pregnant or nursing women should avoid taking this medication, and if nursing, they should discontinue either breastfeeding or the medication. The safety of this medication for children under 18 years of age has not been established, so it is not recommended for use in this age group. Elderly individuals generally do not require dose adjustments, although some elderly patients may be more sensitive to the medication, so caution is advised. This medication should not be administered to patients with severe liver dysfunction, and even those with mildly impaired liver function should use it carefully. In case of overdose, hypotension or abnormal heart rhythms may occur, and immediate medical treatment should be sought if symptoms appear. This medication should be stored out of reach of children and not transferred to another container as this helps maintain quality.

Side effects

Headache, dizziness, fainting, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neurocell inflammation, facial paralysis, normal pressure hydrocephalus, spinal stenosis, headache, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening of cerebral infarction, cerebral hemorrhage, liver cancer, colon carcinoma, neoplasm of unspecified type, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, interstitial lung disease, pharyngitis, pneumonia, lung disease, death, worsening of low back pain, osteoarthritis, arthralgia, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, hypertension, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, low back pain, edema, limb pain, peripheral edema, facial edema, fatigue, fever, neck/shoulder pain, fracture, arthralgia, osteoporosis, myalgia, pharyngitis, upper respiratory tract infection, sputum, rhinitis, nosebleed, bronchitis, sensory disturbance, numbness, tremor, hypertonicity, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorder, worsening of chronic renal failure, dysuria, hyperlipidemia, dyslipidemia, purpura, fatty liver, intestinal vascular edema after angiotensin II receptor antagonist use, abdominal pain, nausea, vomiting, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light in. It is also important to maintain a temperature between 1°C and 30°C when storing the medication. This helps preserve its efficacy and safety.

Appearance and packaging

Appearance

Light green, oval-shaped film-coated tablet with rounded edges

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.